Expertos Invitados





ACTUALIZACION EN LA INVESTIGACION DE LA TUBERCULOSIS: 2006-2007

(especial para SIIC © Derechos reservados)
Revisión sobre los avances en epidemiología, patogénesis, inmunología, diagnóstico y tratamiento de la tuberculosis.
Autor:
Wing wai Yew
Columnista Experto de SIIC

Institución:
Grantham Hospital

Artículos publicados por Wing wai Yew
Recepción del artículo
3 de Abril, 2008 		Aprobación
8 de Julio, 2008
Primera edición
3 de Marzo, 2009 		Segunda edición, ampliada y corregida
7 de Junio, 2021

ACTUALIZACION EN LA INVESTIGACION DE LA TUBERCULOSIS: 2006-2007

Resumen
En los últimos años ha habido un florecimiento en la investigación en el campo de la tuberculosis, que incluyó las cuatro áreas principales: epidemiología, patogénesis/inmunología, diagnóstico y tratamiento. Este artículo hace una breve revisión de un número importante de trabajos científicos publicados en 2006 y 2007 que tuvieron una importancia relevante en la comprensión de Mycobacterium tuberculosis y la infección y la enfermedad que causa. Avances científicos relacionados con el diagnóstico y tratamiento que, esperamos, podrían contribuir al control global de la enfermedad.

Palabras clave
tuberculosis, Mycobacterium tuberculosis, epidemiología, inmunología, drogas antituberculosas, tuberculosis multirresistente, multidrug resistant tuberculosis


Artículo completo
(castellano)
Extensión:  +/-8.45 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes

Update in Tuberculosis Research 2006-2007

Abstract
In recent years, there has been flourishing scientific research in the field of tuberculosis (TB), including four main areas - epidemiology, pathogenesis / immunology, diagnosis, and treatment. This article briefly reviews a number of important scientific papers published in 2006 and in 2007 that have a pounding significance in the understanding of Mycobacterium tuberculosis, and the infection and disease it causes. Scientific advances, especially those related to diagnosis and treatment, would hopefully contribute to the global control of TB.

Key words
tuberculosis, Mycobacterium tuberculosis, epidemiology, immunology, antituberculous drugs


Full text
(english)
 para suscriptores/ assinantes
Clasificación en siicsalud
Artículos originales > Expertos del Mundo >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Neumonología
Relacionadas: Atención Primaria, Bioquímica, Diagnóstico por Laboratorio, Educación Médica, Epidemiología, Farmacología, Infectología, Medicina Familiar, Medicina Interna, Salud Pública



Comprar este artículo
Extensión: 8.45 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Enviar correspondencia a:
Wing Wai Yew, Grantham Hospital Tuberculosis and Chest Unit, 125 Wong Chuk Hang Road, Hong Kong, China
Bibliografía del artículo

1. Yew WW, Leung CC. Update in tuberculosis 2005. Am J Respir Crit Care Med 173:491-8, 2006.
2. Sterling TR, Bethel J, Goldberg S, Weinfurter P, Yun L, Horsburgh CR. Tuberculosis Epidemiologic Studies Consortium. The scope and impact of treatment of latent tuberculosis infection in the United States and Canada. Am J Respir Crit Care Med 173:927-31, 2006.
3. Shieh FK, Snyder G, Horsburgh CR, Bernardo J, Murphy C, Saukkonen JJ. Predicting noncompletion of treatment for latent tuberculosis infection: a prospective survey. Am J Respir Crit Care Med 174:717-21, 2006.
4. Cain KP, Haley CA, Armstrong LR, et al. Tuberculosis among foreign-born persons in the United States: achieving tuberculosis elimination. Am J Respir Crit Care Med 175:75-9, 2007.
5. Dahle UR, Eldholm V, Winje BA, Mannsaker T, Heldal E. Impact of immigration on the molecular epidemiology of Mycobacterium tuberculosis in a low-incidence country. Am J Respir Crit Care Med 176:930-5, 2007.
6. Wood R, Middelkoop K, Myer L, et al. Undiagnosed tuberculosis in a community with high HIV prevalence: implications for TB control. Am J Respir Crit Care Med 175:87-93, 2007.
7. De Vries G, Van Hest NA, Richardus JH. Impact of mobile radiographic screening on tuberculosis among drug users and homeless persons. Am J Respir Crit Care Med 176:201-7, 2007.
8. Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 167:335-42, 2007.
9. Leung CC, Lam TH, Chan WM, et al. Lower risk of tuberculosis in obesity. Arch Intern Med 167:1297-304, 2007.
10. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368:1575-80, 2006.
11. Kim HR, Hwang SS, Kim HJ, et al. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Clin Infect Dis 45:1290-5, 2007.
12. Shah NS, Wright A, Bai GH, et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis 13:380-7, 2007.
13. Cooke GS, Campbell SJ, Sillah J, et al. Polymorphism within the interferon / receptor complex is associated with pulmonary tuberculosis. Am J Respir Crit Care Med 174: 339-43, 2006.
14. Fernando SL, Saunders BM, Sluyter R, et al. A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis. Am J Respir Crit Care Med 175:360-6, 2007.
15. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 173: 803-10, 2006.
16. Plessner HL, Lin PL, Kohno T, et al. Neutralization of tumour necrosis factor (TNF) by antibody but not TNF receptor fusion molecule exacerbates chronic murine tuberculosis. J Infect Dis 195:1643-50, 2007.
17. Martineau AR, Wilkinson RJ, Wilkinson KA, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 176:208-13, 2007.
18. Martineau AR, Wilkinson KA, Newton SM, et al. IFN-gamma and TNF-independent vitamin D-inducible human suppression on mycobacteria: the role of cathelicidin LL-37. J Immunol 178:7190-8, 2007.
19. Pai M, Joshi R, Dogra S, et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 174:349-55, 2006.
20. Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, Lalvani A. Dynamic antigen-specific T cell responses following point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 174:831-9, 2006.
21. Aiken AM, Hill PC, Fox A, et al. Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis 6:66, 2006.
22. Ferrara G, Losi G, D'Amico R, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 367:1328-34, 2006.
23. Lee JY, Choi HJ, Park IN, et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 28:24-30, 2006.
24. Chee CB, KhinMar KW, Gan SH, Barkham TM, Pushparani M, Wang YT. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens. Am J Respir Crit Care Med 175:282-7, 2007.
25. Arend SM, Thijsen SF, Leyten EM, et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Care Med 175:618-27, 2007.
26. Rangaka MX, Wilkinson KA, Seldon R, et al. Effect of HIV-1 infection on T-cell based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 175:514-20, 2007.
27. Luetkemeyer AF, Charlebois ED, Florres LL, et al. Comparison of an IFN- release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 175:737-42, 2007.
28. Dewan PK, Grinsdale J, Kawamura LM. Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis 44:69-73, 2007.
29. Kang YA, Lee HW, Hwang SS, et al. Usefulness of whole-blood interferon- assay and interferon- enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 132:959-65, 2007.
30. Detjen AK, Keil T, Roll S, et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 45:322-8, 2007.
31. Jafari C, Ernst M, Kalsdorf B, et al. Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. Am J Respir Crit Care Med 174:1048-54, 2006.
32. Schechter M, Zajdenverg R, Falco G, et al. Weekly rifapentine / isoniazid or daily rifampin / pyrazinamide for latent tuberculosis in household contacts. Am J Respir Crit Care Med 173:922-6, 2006.
33. Burman W, Benator D, Vernon A, et al. Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis. Tuberculosis Trials Consortium. Am J Respir Crit Care Med 173:350-6, 2006.
34. Rosenthal IM, Williams K, Tyagi S, et al. Potent twice-weekly rifapentine-containing regimens in murine tuberculosis. Am J Respir Crit Care Med 174:94-101, 2006.
35. Burman WJ, Goldberg S, Johnson JL, et al. Tuberculosis Trials Consortium. Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. Am J Respir Crit Care Med 174:331-8, 2006.
36. Nahid P, Gonzalez LC, Rudoy I, et al. Treatment outcomes of patients with HIV and tuberculosis. Am J Respir Crit Care Med 175:1199-206, 2007.
37. Chang KC, Leung CC, Yew WW, Tam CM. Standard anti-tuberculosis treatment and hepatotoxicity: do dosing schedules matter? Eur Respir J 29:347-51, 2007.
38. Szklo A, Mello FC, Guerra RL, et al. Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injury. Int J Tuberc Lung Dis 11:775-80, 2007.
39. Torun T, Tahaoglu K, Ozmen, et al. The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 11:979-85, 2007.
40. Somocurcio JG, Sotomayor A, Shin S, et al. Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru. Thorax 62:416-21, 2007.
 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618
Home

Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008